Your browser doesn't support javascript.
loading
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens.
Goffin, J R; Nicholas, G; Mates, M; Tu, D; Chen, E; Laurie, S A; Juergens, R; Robinson, A; Goss, G; Reaume, M; Sun, S; Christink, K; Maize, C; MacFarlan, S; Sun, X; Ritter, H; Seymour, L; Bradbury, P A.
Afiliação
  • Goffin JR; Juravinski Cancer Centre at Hamilton Health Sciences, 699 Concession St, Hamilton, ON, L8V 5C2, Canada. goffin@mcmaster.ca.
  • Nicholas G; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Mates M; Cancer Centre of Southeastern Ontario, Kingston, ON, Canada.
  • Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Chen E; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Laurie SA; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Juergens R; Juravinski Cancer Centre at Hamilton Health Sciences, 699 Concession St, Hamilton, ON, L8V 5C2, Canada.
  • Robinson A; Cancer Centre of Southeastern Ontario, Kingston, ON, Canada.
  • Goss G; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Reaume M; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Sun S; BCCA - Vancouver Cancer Centre, Vancouver, BC, Canada.
  • Christink K; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Maize C; Cancer Centre of Southeastern Ontario, Kingston, ON, Canada.
  • MacFarlan S; Juravinski Cancer Centre at Hamilton Health Sciences, 699 Concession St, Hamilton, ON, L8V 5C2, Canada.
  • Sun X; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Ritter H; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Bradbury PA; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Invest New Drugs ; 37(3): 498-506, 2019 06.
Article em En | MEDLINE | ID: mdl-30317534

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article